KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Total Current Liabilities (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Total Current Liabilities data on record, last reported at $1.1 billion in Q3 2025.

  • For Q3 2025, Total Current Liabilities rose 10.83% year-over-year to $1.1 billion; the TTM value through Sep 2025 reached $1.1 billion, up 10.83%, while the annual FY2024 figure was $994.1 million, 5.78% down from the prior year.
  • Total Current Liabilities reached $1.1 billion in Q3 2025 per CRL's latest filing, up from $1.1 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1.1 billion in Q3 2025 and bottomed at $929.6 million in Q2 2021.
  • Average Total Current Liabilities over 5 years is $1.0 billion, with a median of $1.0 billion recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: grew 27.7% in 2021, then fell 5.78% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $1.0 billion in 2021, then decreased by 1.84% to $1.0 billion in 2022, then grew by 4.03% to $1.1 billion in 2023, then fell by 5.78% to $994.1 million in 2024, then rose by 12.85% to $1.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $1.1 billion in Q3 2025, $1.1 billion in Q2 2025, and $1.1 billion in Q1 2025.